pharmaglobenews, Author at Pharma Globenewswire

Nonalcoholic Steatohepatitis Market Size (7MM) was ~USD 2,114 million in 2023 and is projected to increase at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Nonalcoholic Steatohepatitis Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of Nonalcoholic Steatohepatitis, historical and forecasted epidemiology as well as the Nonalcoholic Steatohepatitis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and

20 March 2026

Uncategorised

Expanding Therapeutic Horizons and Strategic Innovations Shape the Future of Asperger Syndrome Treatment Market

The evolving landscape of neurological and developmental healthcare continues to drive attention toward conditions that require nuanced, individualized approaches. Among these, Asperger Syndrome remains a focal point for clinicians, researchers, and healthcare stakeholders seeking to improve outcomes and quality of life. The

20 March 2026

Uncategorised

Somatotropin Deficiency Market Outlook Expands with Advancements in Hormone Therapies and Diagnostics

The healthcare landscape continues to evolve as endocrine disorders gain increased clinical and commercial attention. Among these, Somatotropin Deficiency – commonly referred to as growth hormone deficiency – has emerged as a critical focus area due to its long-term impact on growth,

20 March 2026

Uncategorised

Plaque Psoriasis Market Outlook 2026–2034 Driven by Innovation, Biologics, and Rising Disease Burden

The Plaque Psoriasis market continues to evolve as one of the most significant segments within dermatology and immunology, driven by innovation, increasing disease awareness, and the introduction of targeted therapies. With a growing patient population and expanding treatment landscape, the market

20 March 2026

Uncategorised

Venous Thromboembolism Market Expands Rapidly with Advancements in Diagnostics, Therapeutics, and Epidemiological Insights Driving Future Growth

The Venous Thromboembolism (VTE) market is witnessing significant expansion, driven by rising incidence rates, advancements in diagnostic technologies, and the introduction of innovative therapeutics. Increasing awareness among healthcare professionals and patients, coupled with improved healthcare infrastructure, is further contributing to the growth

20 March 2026

Uncategorised

Congestive Heart Failure Market Size (7MM) was ~USD 6,900 Million in 2023 and It is expected to grow by 2034, estimates DelveInsight

DelveInsight’s “Congestive Heart Failure Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of Congestive Heart Failure, historical and forecasted epidemiology as well as the Congestive Heart Failure market trends in the United States, EU4 (Germany, France, Italy,

20 March 2026

Uncategorised

Pigment Epithelial Detachment Market Expected to Experience Substantial Expansion Across 7MM, Propelled by Growing Elderly Demographics and Breakthrough Treatments | DelveInsight

The pigment epithelial detachment (PED) market is set for remarkable expansion, underpinned by multiple contributing factors such as a rising geriatric population, breakthroughs in artificial intelligence-based diagnostics, strategic industry partnerships, and the emergence of next-generation treatment modalities. Leading companies operating in the

20 March 2026

Uncategorised

Emerging Therapies Set to Propel the TRK Fusion Cancer Market Through 2032: DelveInsight Report

DelveInsight has released a comprehensive new report, “TRK Fusion Cancer – Market Insights, Epidemiology, and Market Forecast-2032.” This publication offers an in-depth analysis of TRK Fusion Cancer, including historical and projected epidemiology, alongside detailed market trends across the seven major markets (7MM):

20 March 2026

Uncategorised

DelveInsight’s Trichotillomania Market Analysis, Epidemiological Data, and Forecast Through 2032

DelveInsight’s comprehensive report titled “Trichotillomania Market Insights, Epidemiology, and Market Forecast-2032” provides a thorough examination of the condition, including historical and projected epidemiological data alongside emerging market trends across the United States, EU5 nations (Germany, Spain, Italy, France, and the United Kingdom),

20 March 2026

Uncategorised

Transverse Myelitis Market Insights Report 2034 | DelveInsight

DelveInsight’s Transverse Myelitis Market Insights Report 2034 provides the current and forecast market analysis, individual leading Transverse Myelitis companies’ market shares, challenges, market drivers, barriers, trends, and key companies operating in the market. To read more about the latest highlights related to

20 March 2026

pharmaglobenews

Nonalcoholic Steatohepatitis Market Size (7MM) was ~USD 2,114 million in 2023 and is projected to increase at a significant CAGR by 2034, estimates DelveInsight

Expanding Therapeutic Horizons and Strategic Innovations Shape the Future of Asperger Syndrome Treatment Market

Somatotropin Deficiency Market Outlook Expands with Advancements in Hormone Therapies and Diagnostics

Plaque Psoriasis Market Outlook 2026–2034 Driven by Innovation, Biologics, and Rising Disease Burden

Venous Thromboembolism Market Expands Rapidly with Advancements in Diagnostics, Therapeutics, and Epidemiological Insights Driving Future Growth

Congestive Heart Failure Market Size (7MM) was ~USD 6,900 Million in 2023 and It is expected to grow by 2034, estimates DelveInsight

Pigment Epithelial Detachment Market Expected to Experience Substantial Expansion Across 7MM, Propelled by Growing Elderly Demographics and Breakthrough Treatments | DelveInsight

Emerging Therapies Set to Propel the TRK Fusion Cancer Market Through 2032: DelveInsight Report

DelveInsight’s Trichotillomania Market Analysis, Epidemiological Data, and Forecast Through 2032

Transverse Myelitis Market Insights Report 2034 | DelveInsight

Recent Posts

Banner

Newsletter

Authors